VANCOUVER, BC – Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will participate in three upcoming investor conferences. Stifel 2021 Virtual Healthcare Conference, November 16th –… Read More
VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery platform technology, today announced it is receiving advisory… Read More
The Doctors of BC Terry Fox Medal is awarded to outstanding individuals with a track record of making a difference in cancer care. The Terry Fox Medal recognizes individuals conducting… Read More
U.K.’s Medicines and Healthcare Products Regulatory Agency Authorizes Molnupiravir for the Treatment of Mild-to-Moderate COVID-19 in Adults With a Positive SARS-CoV-2 Diagnostic Test and Who Have at Least One Risk… Read More
We are also pleased to announce our 2022 funding competition schedule. Michael Smith Health Research BC’s Scholar and Research Trainee awards provide funding to support BC’s next generation of health… Read More
